Elevance Health Inc Shines in Guru Fundamental Report

Elevance Health Inc receives high marks for strong fundamentals. The report shows a notable interest in ELV based on earnings growth and cash flow metrics, potentially influencing stock prices positively moving forward.

Date: 07-01-2025

AI Rating: 7

Evaluation of Financial Metrics
The report presents a robust evaluation of ELEVANCE HEALTH INC (ELV) based on various guru strategies, particularly highlighting its exceptional performance under the Low PE Investor model. The rating of 98% indicates strong interest in the stock due to its underlying fundamentals and favorable valuation.

Earnings Per Share (EPS)
The EPS Growth is marked as a pass, indicating that Elevance Health has demonstrated consistent earnings growth, which can lead to investor confidence and potential increases in stock prices. Additionally, the Future EPS Growth also passed, suggesting that analysts expect continued growth in earnings.

Sales Growth
The report notes that Sales Growth for ELV also passed, pointing towards the company's ability to increase its revenues over time. This positive metric can enhance its overall financial health, likely attracting more investors.

Free Cash Flow (FCF)
Free Cash Flow also passed, indicating that Elevance Health has sufficiently generated cash after accounting for capital expenditures. This is crucial as it allows the company to invest back into its operations, pay dividends, or reduce debt, which can further enhance shareholder value.

EPS Persistence
Despite the strong performance in multiple categories, the report highlights a failing grade for EPS Persistence. This could raise concerns for investors as it suggests potential volatility or inconsistency in earnings over time, which might negatively impact stock price stability.

In summary, the report exhibits positive signals for Elevance Health primarily due to its high ratings in EPS growth, sales growth, and cash flow generation, but the failure in EPS persistence raises caution. Investors should consider these mixed signals when evaluating stock potential.

Stocks: ELV